Use of an histone deacetylase inhibitor for the treatment of diseases associated with an hpv infection

作者: Frank Rösl , Patrick Finzer , Harald Zur Hausen

DOI:

关键词:

摘要: Described is the use of histone deacetylase inhibitors for treatment a disease, preferably cervical cancer, associated with an HPV infection. Particularly useful are sodium butyrate, phenylbutyrate and trichostatin A.

参考文章(9)
G Vidali, R S Mann, V G Allfrey, L C Boffa, Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. Journal of Biological Chemistry. ,vol. 253, pp. 3364- 3366 ,(1978) , 10.1016/S0021-9258(17)34804-4
Albert Emmanuel Corneille Geerts, Toshiro Niki, Anti-fibrotic medicament ,(1997)
Yasushi Iwamoto, Minoru Yoshida, Teruhiko Beppu, Use of trichostatin compounds for treating tumor cells ,(1986)
Jong-Sup Park, Eun-Joo Kim, Ho-Jeong Kwon, Eun-Seong Hwang, Sung-Eun Namkoong, Soo-Jong Um, Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis Journal of Biological Chemistry. ,vol. 275, pp. 6764- 6769 ,(2000) , 10.1074/JBC.275.10.6764
Paul R Clark, M.Luisa Roberts, Lex M Cowsert, A novel drug screening assay for papillomavirus specific antiviral activity Antiviral Research. ,vol. 37, pp. 97- 106 ,(1998) , 10.1016/S0166-3542(97)00066-1
Young Bae Kim, Kun-Hyung Lee, Kenji Sugita, Minoru Yoshida, Sueharu Horinouchi, Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase Oncogene. ,vol. 18, pp. 2461- 2470 ,(1999) , 10.1038/SJ.ONC.1202564
Wei Zhao, Francisco Noya, Wen Yong Chen, Tim M. Townes, Louise T. Chow, Thomas R. Broker, Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes. Journal of Virology. ,vol. 73, pp. 5026- 5033 ,(1999) , 10.1128/JVI.73.6.5026-5033.1999
Bernard Loev, Edward Neiss, Unsaturated oxyalkylene esters and uses thereof ,(1998)